Los Angeles Biomedical Research Institute
United States of America
Dr. Shen’s research focuses on assessing and improving the outcomes of patients on chronic dialysis, with a particular emphasis on health disparities and medication safety and effectiveness. Her expertise is in analyzing administrative databases (“big data”) using advanced statistical methods that minimize the bias and confounding common in observational studies. She also has an interest in qualitative research, which uncovers patient’s beliefs and perspectives that could be influencing outcomes but that are not currently captured in existing databases.
Outcomes in the dialysis population, medication safety and effectiveness, racial and ethnic disparities in care,chronic dialysis
Use and safety of heparin-free hemodialysis in the USA. Nephrology Dialysis Transplantation
Heparin Use in Hemodialysis Patients following Gastrointestinal Bleeding. American Journal of Nephrology
Outcomes after warfarin initiation in hemodialysis patients with newly diagnosed atrial fibrillation. American Journal of Kidney Diseases